| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.0007 |